Publication | Closed Access
The calreticulin (CALR) exon 9 mutations are promising targets for cancer immune therapy
87
Citations
21
References
2017
Year
MedicineImmunologyImmune Checkpoint InhibitorCancer BiologyCancer Immune TherapyCancer TreatmentCancer GeneticsOncologyCell BiologyTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1